Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.51NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.51NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.51NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.1.9NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.9NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.19NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.19NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.19NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KU.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KU.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KZ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KZ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JQ.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JQ.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JQ.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LA.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LA.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LH.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LH.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LH.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LN.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LN.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.25.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.25.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.25.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.16.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.16.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.16.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.57.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.57.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.57.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.44.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.44.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.44.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.2.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used